Health

Moderna’s mRNA flu shot earns FDA approval after rollercoaster review - Ars Technica

AT

Published by Ars Technica By Beth Mole · 6 August 2026 at 19:31

Moderna’s mRNA flu shot earns FDA approval after rollercoaster review - Ars Technica — Image · Ars Technica

What the report says

Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.

Read the full report at Ars Technica →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting